Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Professional, scientific, and technical services symbols : Bctx save search
BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: -3.83%
H: 0.0%
C: 0.0%
breast cancer preclinical for
BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR
Published: 2024-04-09 (Crawled : 12:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 1.77%
H: 0.0%
C: 0.0%
breast cancer system
BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies
Published: 2024-03-07 (Crawled : 13:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: -0.64%
H: 4.52%
C: -6.45%
breast cancer
BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference
Published: 2024-03-06 (Crawled : 13:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 3.79%
C: -8.24%
conference breast cancer system
BriaCell Provides Update on Alleged Illegal Trading of Public Securities
Published: 2024-02-27 (Crawled : 13:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 1.52%
H: 5.11%
C: 3.0%
update
BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case
Published: 2024-02-07 (Crawled : 13:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 1.69%
H: 0.95%
C: -6.53%
breast cancer
Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing
Published: 2024-02-06 (Crawled : 13:30) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 9.41%
H: 1.16%
C: -3.72%
candidate cancer
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting
Published: 2024-01-31 (Crawled : 04:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 1.16%
H: 0.46%
C: -5.29%
meeting therapeutics results
BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer
Published: 2024-01-04 (Crawled : 14:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 2.8%
H: 8.75%
C: 3.7%
breast cancer
BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients
Published: 2023-12-28 (Crawled : 14:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 1.71%
H: 9.55%
C: 2.43%
breast cancer system advanced response
BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset
Published: 2023-12-20 (Crawled : 13:30) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 1.02%
H: 11.56%
C: 2.51%
BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit
Published: 2023-12-06 (Crawled : 14:30) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 3.23%
H: 0.18%
C: -6.81%
sabcs potential
BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS
Published: 2023-12-06 (Crawled : 14:30) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 3.23%
H: 0.18%
C: -6.81%
breast cancer sabcs topline advanced
BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor
Published: 2023-11-30 (Crawled : 20:00) - biospace.com/
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 0.2%
H: 3.7%
C: 3.12%
tumor
BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ IND
Published: 2023-11-03 (Crawled : 12:30) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: -0.25%
H: 11.73%
C: 9.69%
fda breast cancer tumor
BriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology Candidate
Published: 2023-10-25 (Crawled : 13:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: -0.81%
H: 3.27%
C: -0.82%
candidate breast cancer medical
October is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative Technology
Published: 2023-10-20 (Crawled : 13:30) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 1.29%
H: 0.0%
C: -6.72%
breast cancer technology
BriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) Conferences
Published: 2023-10-18 (Crawled : 13:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: -1.23%
H: 1.42%
C: -4.09%
breast cancer immunotherapy
BriaCell To Host Virtual Key Opinion Leader Event on Bria-IMT™ Potential in Advanced Metastatic Breast Cancer on October 26, 2023
Published: 2023-10-11 (Crawled : 14:00) - biospace.com/
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 1.79%
H: 0.7%
C: -2.81%
breast cancer potential
BriaCell To Host Virtual Key Opinion Leader Event on Bria-IMT™ Potential in Advanced Metastatic Breast Cancer on October 26, 2023 Featuring Dr. Adam M. Brufsky from University of Pittsburgh School of Medicine and Dr. Saranya Chumsri from Mayo Clinic
Published: 2023-10-11 (Crawled : 13:00) - globenewswire.com
BCTX | $2.19 -5.6% -5.94% 140K
|
Professional, Scientific, and T...
|
| O: 1.79%
H: 0.7%
C: -2.81%
breast cancer potential
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.